Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720

被引:36
作者
Gelineau-van Waes, Janee [1 ]
Rainey, Mark A. [1 ]
Maddox, Joyce R. [1 ]
Voss, Kenneth A. [2 ]
Sachs, Andrew J. [1 ]
Gardner, Nicole M. [1 ]
Wilberding, Justin D. [3 ]
Riley, Ronald T. [2 ]
机构
[1] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA
[2] USDA ARS, Toxicol & Mycotoxin Res Unit, RB Russell Res Ctr, Athens, GA 30613 USA
[3] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA
基金
美国国家卫生研究院;
关键词
fumonisin; FTY720; neural tube defect; exencephaly; sphingolipid; ceramide synthase; mycotoxin; sphinganine-1-phosphate; S1P receptors; neural progenitor cells; SPHINGOSINE-1-PHOSPHATE RECEPTORS; NERVOUS-SYSTEM; NULL ALLELE; 1-PHOSPHATE RECEPTORS; BICISTRONIC STRUCTURE; CERAMIDE SYNTHASES; MASS-SPECTROMETRY; CELL-MIGRATION; BIRTH-DEFECTS; SPINA-BIFIDA;
D O I
10.1002/bdra.23074
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: Fumonisin B1 (FB1) is a mycotoxin produced by a common fungal contaminant of corn. Ingestion of FB1-contaminated food is associated with increased risk for neural tube defects (NTDs). FB1 induces NTDs in inbred LM/Bc mice. FB1 inhibits ceramide synthase in de novo sphingolipid biosynthesis, resulting in accumulation of sphinganine and sphinganine-1-phosphate (Sa1P). Sa1P functions as a ligand for a family of G protein-coupled S1P receptors. METHODS: Pregnant SWV and LM/Bc mice were treated with FB1 (20 mg/kg/day intraperitoneally on embryonic day (ED) 7.58.5) or the known S1P receptor agonist FTY720 (10 mg/kg/day oral gavage on ED 6.58.5). LC/MS was used to detect sphingoid base-1-phosphates in maternal blood spots, plasma, and embryonic tissue. Strain-specific SWV and LM/Bc mouse embryonic fibroblasts (MEFs) and serum free mouse embryo (SFME) neural progenitor cells were treated with FB1 (40 mu M for 24 hr) and LC/MS was used to detect sphingoid base-1-phosphates. RESULTS: FTY720 induced NTDs in both the SWV and the LM/Bc strains of mice. Sphinganine-1-P (Sa1P) and FTY720-P were elevated in the blood spots and plasma of mice treated with FB1 or FTY720, respectively. FTY720-P was elevated in ED 9.5 exencephalic embryos. Sa1P was elevated in SFME and MEF cells treated with FB1, and Sa1P was higher in MEFs generated from the FB1-NTDsusceptible LM/Bc strain. CONCLUSIONS: Elevated sphingoid base-1-P after FB1 or FTY720 suggest a potential role for these bioactive lipid ligands and activation of S1P receptor signaling pathways in the failure of neural tube closure after FB1 or FTY720. Sa1P may represent a biomarker for FB1-NTD risk assessment. Birth Defects Research (Part A), 2012. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:790 / 803
页数:14
相关论文
共 85 条
  • [1] Generation and characterization of a Gdf1 conditional null allele
    Bengtsson, Henrik
    Epifantseva, Irina
    Abrink, Magnus
    Kylberg, Annika
    Kullander, Klas
    Ebendal, Ted
    Usoskin, Dmitry
    [J]. GENESIS, 2008, 46 (07) : 368 - 372
  • [2] Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
    Bielawski, Jacek
    Szulc, Zdzislaw M.
    Hannun, Yusuf A.
    Bielawska, Alicja
    [J]. METHODS, 2006, 39 (02) : 82 - 91
  • [3] Trends in the postfortification prevalence of spina bifida and anencephaly in the United States
    Boulet, Sheree L.
    Yang, Quanhe
    Mai, Cara
    Kirby, Russell S.
    Collins, Julianne S.
    Robbins, James M.
    Meyer, Robert
    Canfield, Mark A.
    Mulinare, Joe
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2008, 82 (07) : 527 - 532
  • [4] The immune modulator FTY720 targets sphingosine 1-phosphate receptors
    Brinkmann, V
    Davis, MD
    Heise, CE
    Albert, R
    Cottens, S
    Hof, R
    Bruns, C
    Prieschl, E
    Baumruker, T
    Hiestand, P
    Foster, CA
    Zollinger, M
    Lynch, KR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21453 - 21457
  • [5] Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
    Brinkmann, Volker
    [J]. PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) : 84 - 105
  • [6] Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells
    Callihan, Phillip
    Zitomer, Nicholas C.
    Stoeling, Michael V.
    Kennedy, Perry C.
    Lynch, Kevin R.
    Riley, Ronald T.
    Hooks, Shelley B.
    [J]. NEUROPHARMACOLOGY, 2012, 62 (02) : 988 - 996
  • [7] Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
    Cyster, JG
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 : 127 - 159
  • [8] Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
    Dev, Kumlesh K.
    Mullershausen, Florian
    Mattes, Henri
    Kuhn, Rainer R.
    Bilbe, Graeme
    Hoyer, Daniel
    Mir, Anis
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) : 77 - 93
  • [9] FTY720: Early clinical experience
    Dragun, D
    Fritsche, L
    Boehler, T
    Peters, H
    Budde, K
    Neumayer, HH
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 544S - 548S
  • [10] Generation of a conditional Ppap2b/Lpp3 null allele
    Escalante-Alcalde, Diana
    Sanchez-Sanchez, Roberto
    Stewart, Colin L.
    [J]. GENESIS, 2007, 45 (07) : 465 - 469